Could It Be That Simple – Or That Hard?

Alzheimer’s is the dread condition of health care policymakers, payers, and all of us who are health care consumers. The policymaker issue is the rising incidence of Alzheimer’s – 11.7% Of Americans Over Age 65 Had Alzheimer’s Disease In 2010; Prevalence Expected To Reach 15.5% By 2050 and Alzheimer’s Deaths Underreported By 600%. The payer issue is projected costs – Alzheimer’s Moves To #6 and For Strategic Repositioning, Think Gray. The consumer issues are all too obvious.

For consumers that have developed the disease, there are a limited number of pharmaceutical interventions – far from a . . .